{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pibrozelesin",
  "nciThesaurus": {
    "casRegistry": "154889-68-6",
    "chebiId": "",
    "chemicalFormula": "C32H36BrN5O8",
    "definition": "A semisynthetic water-soluble derivative of the antineoplastic antibiotic duocarmycin B2.  Activated by carboxyl esterase, pibrozelesin alkylates DNA by binding to adenine-thymine (A-T)-rich sequences in the minor groove of DNA, thereby inhibiting DNA replication and inducing apoptosis.",
    "fdaUniiCode": "IHK933KCIC",
    "identifier": "C1542",
    "preferredName": "Pibrozelesin",
    "semanticType": "Antibiotic",
    "subclassOf": [
      "C2156"
    ],
    "synonyms": [
      "Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methy-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7,-trimethoxy-1H-indol-2-yl)carbonyl)-, Methyl Ester (S)",
      "Duocamycin B2 Analog",
      "KW 2189",
      "KW-2189",
      "KW2189",
      "PIBROZELESIN",
      "Pibrozelesin"
    ]
  }
}